Christopher Jenkins, a 47-year-old from Cassopolis, Michigan, has faced six cancers since 1999 and continues treatment for ...

The risk of embolisms among patients with cancer was recently brought into the spotlight with the Jan. 30 death of “Schitt’s ...

Charles Walker discusses living liver donation, survivorship challenges and why self-advocacy and awareness are vital for patients with liver cancer ...

In an interview with CURE, she urges survivors to pay attention to red flags such as abnormal bleeding, pain or digestive changes and to push for further evaluation if symptoms are dismissed. She also ...

Her friend who lived and worked close by would pop in on the way to or from a shift just to say hello and catch her up with the latest. They would talk music and movies and TV shows and anything that ...

Christopher Jenkins, a 47-year-old from Cassopolis, Michigan, has faced six cancers since 1999 and continues treatment for his latest diagnosis with chemotherapy every 21 days. Six-time cancer ...

The U.S. FDA has granted orphan drug designation to HCB101, an investigational immunotherapy, for the treatment of gastric cancer.

The single-arm trial followed 63 adults with lower-grade gliomas treated with proton therapy. After five years, 79.1% of patients remained free from tumor progression. Overall survival reached 85.6%.

A Clayman Thyroid Center report aims to clarify FDA safety warnings, finding no evidence that GLP-1 drugs like Ozempic cause common thyroid cancers. Current human data do not show a link between GLP-1 ...

Heather Quintana Suchan, a mother and music industry professional living with stage 4 lung cancer, shared how her diagnosis ...

A prolonged disease trajectory complicates “survivor” identity, particularly when remission follows transplant yet later ...

Chris Draft said patients with lung cancer and their caregivers can regain control after diagnosis by showing up, staying ...